Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt/β-catenin signaling pathway
- 31 October 2022
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 302 (Pt A) , 115885
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancerMolecular Cancer, 2017
- Inhibition of N-methyl-N-nitrosourea-induced gastric tumorigenesis by Liuwei Dihuang Pill in db/db miceWorld Journal of Gastroenterology, 2017
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancerNature, 2015
- A polysaccharide from cultured mycelium of Hericium erinaceus and its anti-chronic atrophic gastritis activityInternational Journal of Biological Macromolecules, 2015
- Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western populationBMJ, 2015
- Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial‐to‐mesenchymal transitionMolecular Oncology, 2015
- Alkyl esters of gallic acid as anticancer agents: A reviewEuropean Journal of Medicinal Chemistry, 2013
- Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activityToxicology and Applied Pharmacology, 2013
- The gastric precancerous cascadeJournal of Digestive Diseases, 2011
- Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-κB activity and downregulation of PI3K/AKT/small GTPase signalsFood and Chemical Toxicology, 2010